guest ::
Theranostic application of radiolabeled HER2-targeting single-domain antibodies (RAD202) in preclinical setting
; ; ; ; ; ; ; ; ;
In
Scientific reports 15(1), Seiten/Artikel-Nr.:38468
2025
Online
DOI: 10.1038/s41598-025-25679-w
DOI: 10.18154/RWTH-2025-09966
URL: https://publications.rwth-aachen.de/record/1022348/files/1022348.pdf
Einrichtungen
Projekte
- OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF) (021000-OAPKF)
- GRK 2375 - GRK 2375: Tumor-Targeted Drug Delivery (331065168) (331065168)
- DFG project G:(GEPRIS)445703531 - KFO 5011: Integration neuer Methoden zur Verbesserung von translationaler Nierenforschung (445703531) (445703531)
- DFG project G:(GEPRIS)321137804 - FOR 2591: Severity assessment in animal-based research (321137804) (321137804)
Thematische Einordnung (Klassifikation)
DDC: 600
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-105020880069
WOS Core Collection: WOS:001609822700010
PubMed: pmid:41188605
Interne Identnummern
RWTH-2025-09966
Datensatz-ID: 1022348
Beteiligte Länder
Australia, Germany, Jordan, Netherlands
; 
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
|
The record appears in these collections: |
| Typ | Amount | VAT | Currency | Share | Status | Cost centre |
| Other | 100.00 | 7.00 | EUR | 5.09 % | (DEAL) | 021000-934510 |
| APC | 1864.65 | 130.53 | EUR | 94.91 % | (DEAL) | 021000-934510 |
| Sum | 1964.65 | 137.53 | EUR | |||
| Total | 2102.18 |
PDF